Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# Allow crawling of all content User-agent: * |
Title | Vibliome |
Description | About Vibliome is developing a new family of therapeutics for the treatment of cancer, contraception and other indications, based upon a novel, focused library of inhibitors of validated and promising kinase targets and their escape |
Keywords | kinase, kinase inhibitor, oncology, molecule, medicinal, chemistry, signaling, drug, biotechnology, pharma |
WebSite | vibliome.com |
Host IP | 23.229.226.9 |
Location | United States |
Site | Rank |
US$2,966,511
Last updated: 2023-05-17 00:57:56
vibliome.com has Semrush global rank of 3,567,930. vibliome.com has an estimated worth of US$ 2,966,511, based on its estimated Ads revenue. vibliome.com receives approximately 342,290 unique visitors each day. Its web server is located in United States, with IP address 23.229.226.9. According to SiteAdvisor, vibliome.com is safe to visit. |
Purchase/Sale Value | US$2,966,511 |
Daily Ads Revenue | US$2,739 |
Monthly Ads Revenue | US$82,150 |
Yearly Ads Revenue | US$985,795 |
Daily Unique Visitors | 22,820 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
vibliome.com. | A | 10800 | IP: 23.229.226.9 |
vibliome.com. | NS | 3600 | NS Record: ns40.domaincontrol.com. |
vibliome.com. | NS | 3600 | NS Record: ns39.domaincontrol.com. |
vibliome.com. | MX | 3600 | MX Record: 20 mx2-us1.ppe-hosted.com. |
vibliome.com. | MX | 3600 | MX Record: 10 mx1-us1.ppe-hosted.com. |
vibliome.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com a:dispatch-us.ppe-hosted.com ~all |
vibliome.com. | TXT | 3600 | TXT Record: ppe-8276838fa144a30c4b7488788b3d268af8d80c66 |
vibliome.com. | TXT | 3600 | TXT Record: 0ed1fe018ab538d0bafb774e8587ec14b524934e3b |
vibliome.com. | TXT | 3600 | TXT Record: zoho-verification=zb87412143.zmverify.zoho.com |
vibliome.com. | TXT | 3600 | TXT Record: v=verifydomain MS=3533484 |
About Programs Careers News Team Contact Vibliome Therapeutics, LLC, has developed a new, systematic approach that enables the design of small molecule Type II kinase inhibitors with unique profiles and a high degree of selectivity Learn More About Vibliome Kinases are key regulators of cell function that represent one of the largest and most functionally diverse gene families. There are over 500 kinase enzymes encoded by the human genome which control nearly all cellular functions by phosphorylating proteins and other molecules. Aberrations in these cell signaling pathways affect cell metabolism, division, activation, growth and death, and are hallmarks in the development of cancer as well as other chronic diseases. Kinase inhibitors have been shown to be effective in targeting these aberrant signaling mechanisms that drive disease progression, yet currently-approved inhibitors act against fewer than 40 kinase targets. In contrast to target-driven high-throughput screening |
HTTP/1.1 301 Moved Permanently Date: Fri, 25 Feb 2022 09:16:06 GMT Server: Apache Location: https://vibliome.com/ Cache-Control: max-age=0 Expires: Fri, 25 Feb 2022 09:16:06 GMT Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 last-modified: Wed, 23 Feb 2022 18:18:35 GMT accept-ranges: bytes content-length: 26322 cache-control: max-age=0 expires: Fri, 25 Feb 2022 09:16:07 GMT vary: Accept-Encoding x-ua-compatible: IE=edge x-content-type-options: nosniff content-type: text/html; charset=utf-8 date: Fri, 25 Feb 2022 09:16:07 GMT server: Apache |
Domain Name: VIBLIOME.COM Registry Domain ID: 2125298369_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-05-18T14:40:20Z Creation Date: 2017-05-17T18:28:42Z Registry Expiry Date: 2023-05-17T18:28:42Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS39.DOMAINCONTROL.COM Name Server: NS40.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-02-25T10:02:20Z <<< |